Published on November 18, 2019
|Abbreviations and acronyms|
|Health care systems require Tc‑99m to maintain patient care|
|The use of nuclear medicine diagnostics and Tc-99m varies significantly across countries|
|Health care providers have varying incentives to contain the cost of Tc-99m|
|The Tc-99m supply chain is technically complex and characterised by market imperfections|
|Barriers to Full-Cost Recovery and Policy Options|
Annexes4 chapters available
The Supply of Medical Radioisotopes: An Economic Diagnosis and Possible Solutions
18 November 2019
14:30-16:00 Paris time
The Nuclear Energy Agency (NEA) will host a webinar on 18 November 2019 to present findings from a new report on the supply of medical radioisotopes, jointly produced with the Organisation for Economic Co-operation and Development (OECD) Health Committee.
Join William D. Magwood, IV, Director General of the NEA, Mark Pearson, Deputy Director of Employment, Labour and Social Affairs at the OECD, Jan Horst Keppler, Senior Economist at the NEA, and Martin Wenzl, Health Policy Analyst at the OECD, to hear the key findings of this new joint report.
Interested professionals, journalists and members of the public who would like to be able to submit questions before or during the webinar can send them via Twitter @OECD_NEA or e-mail to email@example.com.
The webinar is available on the OECD Web TV:
Follow us on Twitter via @OECD_Social